Janux Therapeutics Cash Flow Statement (2020-2026) | JANX

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Cash Flow Statement	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026
Operating Activities
Net Income (Quarter)	-6.21M	-10.77M	-13.42M	-13.41M	-16.89M	-16.70M	-16.07M	-17.46M	-17.51M	-11.57M	-11.76M	-14.76M	-5.96M	-28.06M	-20.22M	-23.51M	-33.86M	-24.31M	-31.95M	-24.36M
Depreciation and Depletion (Quarter)	0.01M	0.03M	0.06M	0.08M	0.11M	0.25M	0.40M	0.45M	0.47M	0.50M	0.53M	0.53M	0.51M	0.51M	0.51M	0.52M	0.54M	0.50M	0.47M	0.47M
Share-based Compensation (Quarter)	1.28M	2.57M	2.94M	3.96M	4.44M	4.60M	4.21M	5.47M	5.50M	4.55M	4.48M	5.62M	5.76M	15.39M	6.25M	10.70M	10.96M	9.04M	9.52M	9.27M
Gains from Sales and Divestitures (Quarter)														0.00M	0.00M		0.00M	0.01M	0.02M	0.12M
Gains from Investment Securities (Quarter)	0.02M	0.01M	-0.74M	0.10M	-0.34M	-0.37M	0.59M	1.50M	9.08M	0.64M	0.76M	5.60M	-1.09M	9.45M	-7.17M	3.00M	1.63M	9.95M	6.96M	1.34M
Non-cash Items (Quarter)	90.41M	72.67M	62.95M	35.02M	5.01M	5.14M	29.81M	5.30M	22.99M	5.41M	16.73M	253.76M	5.64M	5.72M	361.60M	6.23M	6.54M	6.80M	29.60M	6.88M
Cash from Operations (Quarter)	-6.20M	-5.85M	-10.48M	-11.52M	-6.07M	-13.41M	-11.91M	-13.91M	-15.05M	-11.71M	-9.90M	-14.84M	-10.02M	-2.23M	-16.73M	-17.02M	-23.81M	-12.86M	-28.54M	-12.34M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter)	0.04M	0.08M	0.06M	0.02M	0.10M	0.77M	1.29M	1.68M	1.84M	2.11M	2.06M	1.79M	2.97M	2.90M	2.93M	4.22M	5.21M	4.62M	3.52M	2.62M
Depreciation & Amortization (CF) (Quarter)	0.01M	0.03M	0.06M	0.08M	0.11M	0.25M	0.40M	0.45M	0.47M	0.50M	0.53M	0.53M	0.51M	0.51M	0.51M	0.52M	0.54M	0.50M	0.47M	0.47M
Change in Working Capital
Change in Receivables (Quarter)		-0.38M				0.50M	-0.50M	0.75M	-0.75M			0.52M	6.98M							35.00M
Change in Account Payables (Quarter)	-0.31M	2.58M	-0.48M	-0.74M	0.86M	-0.63M	0.22M	-0.11M	-0.17M	0.23M	0.33M	-0.46M	-0.69M	1.18M	1.56M	-1.64M	1.11M	-0.17M	1.67M	-1.61M
Change in Accured Expenses (Quarter)	0.94M	0.41M	1.92M	1.16M	-0.89M	2.89M	1.00M	-0.56M	1.44M	-1.99M	0.43M	-1.57M	3.06M	4.57M	-1.63M	1.73M	2.89M	6.18M	-4.52M	-2.03M
Investing Activities
Capital Expenditures (Quarter)	-0.00M	0.31M	1.17M	0.40M	1.47M	2.52M	2.06M	0.28M	0.17M	-0.03M	-0.30M		0.29M	-0.25M	0.32M	0.37M	0.47M	-0.74M	0.94M	0.27M
Change in Acquisitions & Divestments (Quarter)		22.14M	112.00M	77.10M	78.75M	116.75M	86.50M	63.25M	95.00M	75.00M	44.75M	65.00M	44.75M	45.16M	58.00M	31.27M	94.72M	126.37M	152.93M	121.31M
Cash from Investing Activities (Quarter)	-142.60M	-205.54M	7.33M	31.07M	9.04M	19.76M	-1.60M	-8.74M	17.87M	-61.45M	11.12M	-113.74M	-190.88M	12.67M	33.93M	-340.39M	1.56M	8.31M	29.54M	8.29M
Financing Activities
Other financing activities (Quarter)																0.35M
Debt Issuance and Repayment
Long-Term Debt Issuances (Quarter)	68.83M
Change in Capital Stock
Shares Issued (Quarter)		-0.84M						1.58M				1.66M				0.90M				3.54M
Misc.
Cash from Financing Activities (Quarter)	329.66M	-0.84M	0.16M	0.00M	0.31M		0.19M	1.58M	0.53M	56.61M	0.83M	322.17M	2.77M	1.65M	386.65M	0.55M	0.95M	0.49M	2.94M	3.54M
Change in Cash (Quarter)	180.86M	-212.24M	-2.99M	19.55M	3.27M	6.35M	-13.33M	-21.07M	3.35M	-16.55M	2.05M	193.60M	-198.14M	12.09M	403.85M	-356.86M	-21.30M	-4.06M	3.94M	-0.51M
Free Cash Flow (Quarter)	-6.20M	-6.16M	-11.65M	-11.92M	-7.55M	-15.93M	-13.97M	-14.20M	-15.23M	-11.68M	-9.60M	-14.84M	-10.31M	-1.98M	-17.04M	-17.39M	-24.29M	-12.11M	-29.48M	-12.61M
Net Cash Flow (Quarter)	180.86M	-212.24M	-2.99M	19.55M	3.27M	6.35M	-13.33M	-21.07M	3.35M	-16.55M	2.05M	193.60M	-198.14M	12.09M	403.85M	-356.86M	-21.30M	-4.06M	3.94M	-0.51M

Research Tools

Developers

Janux Therapeutics Cash Flow Statement (2020-2026) | JANX

Research Tools

Developers

Janux Therapeutics Cash Flow Statement (2020-2026) | JANX

Create an account

Sign In

Reset Password